欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2430/002
药品名称PediSMOF Infant
活性成分
    • Alanine 6.3 mg/ml
    • Arginine 4.1 mg/ml
    • Aspartic acid 4.1 mg/ml
    • Calcium gluconate, anhydrous 12.3 mg/ml
    • Cysteine 1.0 mg/ml
    • FISH OIL, RICH IN OMEGA-3-ACIDS 30.0 mg/ml
    • Glucose 196.0 mg/ml
    • Glutamic acid 7.1 mg/ml
    • Glycine 2.1 mg/ml
    • Histidine 2.1 mg/ml
    • Isoleucine 3.1 mg/ml
    • Leucine 7.0 mg/ml
    • Lysine 5.54 mg/ml
    • Magnesium sulfate 0.45 mg/ml
    • Methionine 1.3 mg/ml
    • OLIVE OIL, REFINED 50.0 mg/ml
    • Phenylalanine 2.7 mg/ml
    • Potassium chloride 3.48 mg/ml
    • Proline 5.6 mg/ml
    • Serine 3.8 mg/ml
    • SODIUM GLYCEROPHOSPHATE ANHYDROUS 5.54 mg/ml
    • SOYA-BEAN OIL REFINED 60.0 mg/ml
    • Taurine 0.3 mg/ml
    • Threonine 3.6 mg/ml
    • TRIGLYCERIDES, MEDIUM CHAIN 60.0 mg/ml
    • Tryptophan 1.4 mg/ml
    • Tyrosine 0.5 mg/ml
    • Valine 3.6 mg/ml
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Italy (IT)
    • Croatia (HR)
    • Norway (NO)
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      PediSMOF 2 Emulsion zur Infusion
    • Finland (FI)
    • Denmark (DK)
    • Poland (PL)
    • Belgium (BE)
    • Latvia (LV)
    • Netherlands (NL)
    • Lithuania (LT)
    • Iceland (IS)
    • Estonia (EE)
    • Ireland (IE)
    • Hungary (HU)
      PediSMOF 2 emulsion for infusion
    • Austria (AT)
    • Czechia (CZ)
      PediSMOF 2
    • France (FR)
    • Romania (RO)
    • Spain (ES)
    • Slovakia (SK)
    • Portugal (PT)
    • Slovenia (SI)
许可日期2025/06/26
最近更新日期2025/06/27
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase